Genotype Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Genotype clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Retinal DiseaseGenotype
National Eye Institute (NEI)320 enrolled1 locationNCT01145196
Recruiting

Natural History Study of Inherited Retinal Diseases

MutationMacular DegenerationRetinal Dystrophies+7 more
Zhongmou Therapeutics200 enrolled1 locationNCT07085533
Recruiting

Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

PhenotypeGenotypeCorrection+4 more
Ain Shams University25 enrolled1 locationNCT07138963
Recruiting

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

PregnancyRhesus D Genotype
Devyser Inc.500 enrolled1 locationNCT06690099
Recruiting
Not Applicable

The Study of the Phenotype of Hereditary Xerocytosis

PhenotypeGenotypeXerocytosis
Centre Hospitalier Universitaire, Amiens20 enrolled1 locationNCT06892171
Recruiting

AI-Driven Genotype Prediction Using EHR and Multimodal Data

Genotype
The Eye Hospital of Wenzhou Medical University100,000 enrolled4 locationsNCT06791421
Recruiting
Phase 4

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Not Applicable

FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort

Cardiovascular DiseasesCohort StudiesRisk Factors+2 more
Central Hospital, Nancy, France3,000 enrolled1 locationNCT05916287